Institutional Fund
Investor Ab
Stockholm, SwedenCIK 8892325 filings on record
Portfolio Value
$15.12B
Q1 2026
Holdings
10
Reported positions
New Buys
4
Opened this quarter
QoQ Change
+166.6%
from $5.67B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Astrazeneca PLC67.3%
- Nasdaq Inc32.6%
- Mediwound Ltd0.1%
- Cellebrite Di Ltd0.0%
- Coherent Corp0.0%
- Kyivstar Group Ltd0.0%
Portfolio Holdings
10 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Astrazeneca PLC | 51.59M | $10.17B | 67.3% | +51.59M | New |
| 2 | Nasdaq Inc | 58.38M | $4.93B | 32.6% | +200.0K | Added |
| 3 | Mediwound Ltd | 872.1K | $14.05M | 0.1% | 0 | Held |
| 4 | Cellebrite Di Ltd | 55.0K | $757.9K | 0.0% | +55.0K | New |
| 5 | Coherent Corp | 3.0K | $714.6K | 0.0% | −3.0K | Reduced |
| 6 | Kyivstar Group Ltd | 59.4K | $601.1K | 0.0% | +59.4K | New |
| 7 | Verizon Communications Inc | 11.3K | $567.3K | 0.0% | +11.3K | New |
| 8 | Corsair Gaming Inc | 99.7K | $553.4K | 0.0% | −25.0K | Reduced |
| 9 | Whirlpool Corp | 4.7K | $253.4K | 0.0% | +1.0K | Added |
| 10 | Biomarin Pharmaceutical Inc | 3.7K | $209.0K | 0.0% | 0 | Held |